Table:
begin	end	state
1	26	signal peptide
27	40	non-cytoplasmic
41	59	transmembrane
60	79	cytoplasmic
80	100	transmembrane
101	131	non-cytoplasmic
132	152	transmembrane
153	178	cytoplasmic
179	204	transmembrane
205	216	non-cytoplasmic
217	238	transmembrane
239	250	cytoplasmic
251	271	transmembrane
272	305	non-cytoplasmic
306	324	transmembrane
325	334	cytoplasmic
335	359	transmembrane
360	391	non-cytoplasmic
392	418	transmembrane
419	433	cytoplasmic
434	456	transmembrane
457	461	non-cytoplasmic
462	482	transmembrane
483	525	cytoplasmic

Input:
>WP_057509185.1 NCBI__GCF_001431535.1:WP_057509185.1
MVFRISIALVAVLVLLAGLAPDAFNSVVQTVLAEVVRGAGWLYLLVVFLALSFLLYLAFG
RFANLRIGGEDAEPDFSRASWMSMLFAAGMGIGLVFWGAAEPVSHFVKPPEGLEPMGMEA
ARASMRYAFFHWGLHPWAIYALIGLAMAWFQFNRNGRGLVSDMLQPIIGHHHRGWIGQVV
NIAAVVATAIGVATTLGFGTIQIAAGLERVFGIPSNVPTQMVIIAVAFVLYMASTMSGVD
RGIKWLSNFNLGLAALLLAMVLVLGPTGFIFDTFTTTLGSYLNQLVTMSLRMSPFSGSTW
VVDWTIFYWAWWIAWAPFVGAFIARISRGRSVREFVVGVVIAPTVLGFIWFSVFGGTALW
SQIFGHVDLVAALGNGYETVLFTMFDSLPLPLVLASVALVLLMIFFVTSADSAVLVLASM
STDEAGDPPLKRKVAWGVAIALIAAALLLAGGLAALQGMITIAALPFALLMILVMVSLYR
VLDQEWTRERRKAQRARQMIESWIEREMAAQEETRQEAGRAAERD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server